LRI Investments LLC Sells 584 Shares of Maximus, Inc. $MMS

LRI Investments LLC trimmed its stake in shares of Maximus, Inc. (NYSE:MMS) by 31.9% in the second quarter, HoldingsChannel.com reports. The fund owned 1,249 shares of the health services provider’s stock after selling 584 shares during the quarter. LRI Investments LLC’s holdings in Maximus were worth $88,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the stock. CWM LLC lifted its position in shares of Maximus by 218.6% during the 2nd quarter. CWM LLC now owns 7,244 shares of the health services provider’s stock valued at $509,000 after acquiring an additional 4,970 shares during the period. Vanguard Personalized Indexing Management LLC lifted its position in shares of Maximus by 32.1% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 8,607 shares of the health services provider’s stock valued at $604,000 after acquiring an additional 2,092 shares during the period. Inspire Investing LLC lifted its position in shares of Maximus by 251.8% during the 2nd quarter. Inspire Investing LLC now owns 17,751 shares of the health services provider’s stock valued at $1,246,000 after acquiring an additional 12,705 shares during the period. Blue Trust Inc. lifted its position in shares of Maximus by 31.0% during the 2nd quarter. Blue Trust Inc. now owns 1,609 shares of the health services provider’s stock valued at $113,000 after acquiring an additional 381 shares during the period. Finally, Total Wealth Planning & Management Inc. lifted its position in shares of Maximus by 13.1% during the 2nd quarter. Total Wealth Planning & Management Inc. now owns 5,875 shares of the health services provider’s stock valued at $412,000 after acquiring an additional 679 shares during the period. 97.21% of the stock is currently owned by institutional investors.

Maximus Price Performance

Maximus stock opened at $85.31 on Tuesday. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $4.81 billion, a PE ratio of 15.71 and a beta of 0.57. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.73. The stock has a 50-day moving average price of $86.92 and a two-hundred day moving average price of $76.33.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.39 by $0.77. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The business’s quarterly revenue was up 2.5% on a year-over-year basis. During the same period last year, the company earned $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 1st. Shareholders of record on Friday, November 14th will be given a $0.30 dividend. The ex-dividend date is Friday, November 14th. This represents a $1.20 annualized dividend and a yield of 1.4%. Maximus’s dividend payout ratio (DPR) is currently 22.10%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on MMS. Weiss Ratings upgraded Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, October 8th. Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating and two have given a Buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $90.00.

Insider Buying and Selling

In other Maximus news, insider Michelle F. Link sold 1,610 shares of the stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the transaction, the insider directly owned 13,508 shares in the company, valued at approximately $1,227,336.88. This trade represents a 10.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.60% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.